Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
589 ARTÍCULOS , VIENDO DEL 526 AL 540
Potential Protein Blood-based Biomarkers in Different Types of Dementia: A Therapeutic Overview
Manzine PR, Vatanabe IP, Grigoli MM, Pedroso RV, Monteiro MPAO, Oliveira DSMS, Nascimento CMC, Peron R, Orlandi FS, Cominetti MR.
Curr Pharm Des. 2022;28(14):1170-1186. doi: 10.2174/1381612828666220408124809.
Influencing factors and characterization methods of nanoparticles regulating amyloid aggregation
Li L, Liu J, Li X, Tang Y, Shi C, Zhang X, Cui Y, Wang L, Xu W.
Soft Matter. 2022 May 4;18(17):3278-3290. doi: 10.1039/d1sm01704g.
Molecular interaction of stress granules with Tau and autophagy in Alzheimer's disease
Yu QY, Ye LQ, Li HL.
Neurochem Int. 2022 Jul;157:105342. doi: 10.1016/j.neuint.2022.105342. Epub 2022 Apr 21.
Targeting Insulin-Like Growth Factor-I in Management of Neurological Disorders
Makkar R, Behl T, Sehgal A, Singh S, Sharma N, Makeen HA, Albratty M, Alhazmi HA, Meraya AM.
Neurotox Res. 2022 Jun;40(3):874-883. doi: 10.1007/s12640-022-00513-7. Epub 2022 Apr 27.
Merighi S, Borea PA, Varani K, Vincenzi F, Travagli A, Nigro M, Pasquini S, Suresh RR, Kim SW, Volkow ND, Jacobson KA, Gessi S.
Molecules. 2022 Apr 21;27(9):2680. doi: 10.3390/molecules27092680.
The role of basket trials in drug development for neurodegenerative disorders
Cummings J, Montes A, Kamboj S, Cacho JF.
Alzheimers Res Ther. 2022 May 25;14(1):73. doi: 10.1186/s13195-022-01015-6.
Applications of Gold Nanoparticles in Brain Diseases across the Blood-Brain Barrier
Zhang J, Yang T, Huang W, Yu Y, Sun T.
Curr Med Chem. 2022;29(39):6063-6083. doi: 10.2174/0929867329666220527121943.
Mahapatra MK, Karuppasamy M, Sahoo BM.
Pharm Res. 2022 Jun;39(6):1233-1248. doi: 10.1007/s11095-022-03302-1. Epub 2022 Jun 1.
Emerging therapeutic developments in neurodegenerative diseases: A clinical investigation
Kumar D, Md Ashraf G, Bilgrami AL, Imtaiyaz Hassan M.
Drug Discov Today. 2022 Oct;27(10):103305. doi: 10.1016/j.drudis.2022.06.005. Epub 2022 Jun 18.
Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases
Fan Y, Chen Z, Zhang M.
J Transl Med. 2022 Jun 27;20(1):291. doi: 10.1186/s12967-022-03493-6.
Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease
Khezri MR, Ghasemnejad-Berenji M.
Neurochem Res. 2022 Oct;47(10):2954-2962. doi: 10.1007/s11064-022-03667-0. Epub 2022 Jul 8.
GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight
Monti G, Gomes Moreira D, Richner M, Mutsaers HAM, Ferreira N, Jan A.
Cells. 2022 Jun 25;11(13):2023. doi: 10.3390/cells11132023.
Inosine in Neurodegenerative Diseases: From the Bench to the Bedside
Basile MS, Bramanti P, Mazzon E.
Molecules. 2022 Jul 21;27(14):4644. doi: 10.3390/molecules27144644.
Targeting endoplasmic reticulum stress using natural products in neurological disorders
Jangra A, Verma M, Kumar D, Chandrika, Rachamalla M, Dey A, Dua K, Jha SK, Ojha S, Alexiou A, Kumar D, Jha NK.
Neurosci Biobehav Rev. 2022 Oct;141:104818. doi: 10.1016/j.neubiorev.2022.104818. Epub 2022 Aug 5.
Aborode AT, Pustake M, Awuah WA, Alwerdani M, Shah P, Yarlagadda R, Ahmad S, Silva Correia IF, Chandra A, Nansubuga EP, Abdul-Rahman T, Mehta A, Ali O, Amaka SO, Zuñiga YMH, Shkodina AD, Inya OC, Shen B, Alexiou A.
Oxid Med Cell Longev. 2022 Jul 31;2022:7934442. doi: 10.1155/2022/7934442. eCollection 2022.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.